About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harrow, Inc. - Common Stock (NQ:HROW)

33.93 -0.51 (-1.48%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,162,589
Open 34.00
Bid (Size) 34.31 (300)
Ask (Size) 34.79 (200)
Prev. Close 34.44
Today's Range 32.68 - 34.08
52wk Range 20.85 - 54.19
Shares Outstanding 37,002,136
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Could Harrow's New Sedation Pill Change Millions Of Medical Procedures Forever?
Harrow, Inc. (NASDAQ: HROW), a U.S.-based provider of ophthalmic disease management solutions, announced on Friday that it has agreed to acquire Melt 
Via Benzinga
Harrow To Acquire Sedation Solutions Developer Melt Pharmaceuticals – More Details Inside
Via Stocktwits

Performance

YTD
-7.2%
-7.2%
1 Month
-14.6%
-14.6%
3 Month
-1.5%
-1.5%
6 Month
+39.1%
+39.1%
1 Year
-32.0%
-32.0%

More News

Read More
Demystifying Harrow: Insights From 5 Analyst Reviews
Via Benzinga
Tesla To Rally Around 4%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
HARROW INC (NASDAQ:HROW) Presents High Growth Momentum and Technical Breakout Opportunity
Via Chartmill
A Preview Of Harrow's Earnings
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
Earnings Scheduled For August 11, 2025
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States
From Harrow, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
HROW Investors Have Opportunity to Join Harrow, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications
From Harrow, Inc.
Via Business Wire
William Blair Bullish On Harrow's High-Margin Branded Eye Drug Strategy
Via Benzinga
Assessing Harrow: Insights From 4 Financial Analysts
Via Benzinga

Frequently Asked Questions

Is Harrow, Inc. - Common Stock publicly traded?
Yes, Harrow, Inc. - Common Stock is publicly traded.
What exchange does Harrow, Inc. - Common Stock trade on?
Harrow, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Harrow, Inc. - Common Stock?
The ticker symbol for Harrow, Inc. - Common Stock is HROW on the Nasdaq Stock Market
What is the current price of Harrow, Inc. - Common Stock?
The current price of Harrow, Inc. - Common Stock is 33.93
When was Harrow, Inc. - Common Stock last traded?
The last trade of Harrow, Inc. - Common Stock was at 11/07/25 04:00 PM ET
What is the market capitalization of Harrow, Inc. - Common Stock?
The market capitalization of Harrow, Inc. - Common Stock is 1.26B
How many shares of Harrow, Inc. - Common Stock are outstanding?
Harrow, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.